SEAL Therapeutics AG
Gene therapy for muscular dystrophy
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
28.03.2023
Basel Innovation: Schub für universitäres Unternehmertum (startupticker.ch)
01.03.2022
New start-up takes over gene therapy approach for a rare disease from Santhera (startupticker.ch)
No milestones
No Jobs
No videos and documents
SEAL Therapeutics AG
Gene therapy for muscular dystrophy
Website:
www.biozentrum.unibas.ch/research/technology-ventures/overview-3
Headquarter:
Basel
Foundation Date:
September 2021
Technology:
- Biotech